全文获取类型
收费全文 | 683篇 |
免费 | 55篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 21篇 |
妇产科学 | 29篇 |
基础医学 | 113篇 |
口腔科学 | 18篇 |
临床医学 | 38篇 |
内科学 | 213篇 |
皮肤病学 | 18篇 |
神经病学 | 45篇 |
特种医学 | 15篇 |
外科学 | 89篇 |
综合类 | 5篇 |
预防医学 | 53篇 |
眼科学 | 9篇 |
药学 | 30篇 |
中国医学 | 5篇 |
肿瘤学 | 35篇 |
出版年
2023年 | 9篇 |
2022年 | 10篇 |
2021年 | 24篇 |
2020年 | 14篇 |
2019年 | 23篇 |
2018年 | 21篇 |
2017年 | 12篇 |
2016年 | 13篇 |
2015年 | 25篇 |
2014年 | 35篇 |
2013年 | 27篇 |
2012年 | 54篇 |
2011年 | 43篇 |
2010年 | 28篇 |
2009年 | 19篇 |
2008年 | 42篇 |
2007年 | 46篇 |
2006年 | 37篇 |
2005年 | 38篇 |
2004年 | 29篇 |
2003年 | 21篇 |
2002年 | 27篇 |
2001年 | 10篇 |
2000年 | 22篇 |
1999年 | 18篇 |
1998年 | 7篇 |
1997年 | 5篇 |
1996年 | 8篇 |
1995年 | 7篇 |
1992年 | 8篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1989年 | 5篇 |
1988年 | 3篇 |
1987年 | 2篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1977年 | 3篇 |
1975年 | 2篇 |
1974年 | 3篇 |
1973年 | 3篇 |
1972年 | 2篇 |
1969年 | 4篇 |
1967年 | 3篇 |
1966年 | 2篇 |
1961年 | 3篇 |
排序方式: 共有744条查询结果,搜索用时 31 毫秒
131.
INTRODUCTION:
PXR polymorphisms have been implicated in modulating CYP3A4 and PXR expression, potentially accounting for interindividual differences in drug metabolism. The prevalence of PXR polymorphisms varies among ethnic groups and data on the allelic distribution in the highly mixed Brazilian population is lacking. The aim of this study was to analyze genetic variations in the PXR gene in Brazilians and to compare the results to other ethnic groups.METHODS:
DNA samples from 117 healthy Brazilians underwent PCR amplification and sequencing.RESULTS:
Eleven polymorphisms were identified, 3 of which are highly associated with differences in CYP3A4 expression. We also identified 1 new synonymous variant in 1.3% of the alleles. Among the functional polymorphisms, –25913 C>T and –6994T>C occurred at a higher frequency compared to the African alleles (p < 0.05) but at a lower frequency compared to Caucasian alleles. The 8055 C>T allele was found at a similar frequency to those described in Caucasians and Africans (p > 0.05).CONCLUSION:
We observed that functional variants of the PXR were frequent in our sample of the Brazilian population. Our results suggest that PXR gene variants may be of interest in pharmacogenetic studies involving Brazilians. 相似文献132.
Twenty-six microbiologically inactive (MIC >?512?μg/mL) convolvulaceous resin glycosides ( 1- 26) were tested for resistance modulatory activity in vitro against Escherichia coli Rosetta-gami and two nosocomial pathogens, Salmonella typhi and Shigella flexneri. These compounds exerted a potentiation effect of the clinically useful antibiotics tetracycline, kanamycin, and chloramphenicol against the tested gram-negative bacteria by increasing antibiotic susceptibility up to 32-fold at concentrations of 25?μg/mL. Therefore, the oligosaccharides from the morning glory family (Convolvulaceae) represent metabolites that reverse microbial resistance mechanisms, favoring an increase in the strength and effectiveness of current antibiotics that are not effective in the treatment of refractive infections caused by multidrug-resistant strains. 相似文献
133.
134.
135.
136.
This study determined whether the cardiac autonomic function of adults with Down syndrome (DS) differs from that of nondisabled persons during submaximal dynamic exercise. Thirteen participants with DS and 12 nondisabled individuals performed maximal and submaximal treadmill tests with metabolic and heart rate (HR) measurements. Spectral analysis of HR variability was performed on the last 256 consecutive R-R intervals obtained under the following conditions: (1) rest, (2) submaximal treadmill exercise (at constant relative intensity below the ventilatory threshold) and (3) recovery. Participants with DS presented lower chronotropic response than those without DS to peak and submaximal exercise (p < 0.05). Nevertheless, the fractional utilization of peak HR during treadmill walking was similar between groups (∼60% peak HR). Even though there were no between-group differences at rest or during recovery, the participants with DS showed a higher LF/HF ratio during exercise (p < 0.05). Similarly, the LF power of participants with DS during exercise was greater than that of nondisabled participants (p < 0.05). In contrast, both groups exhibited similar HF power at each physiological condition. In conclusion, these findings suggest that adults with DS demonstrate appropriate vagal withdrawal, but heightened sympathetic modulation of HR variability at ∼60% of their peak HR. Despite this, the absolute change in HR from rest to exercise was attenuated in these individuals compared to persons without disabilities. This indicates that DS may be associated with poor cardiac responsiveness to changes in autonomic modulation during exercise at intensities below the ventilatory threshold. 相似文献
137.
Michelle Liu Sally Shi Sean Senthilnathan Julie Yu Elliot Wu Carsten Bergmann Klaus Zerres Nadja Bogdanova Eliecer Coto Constantinos Deltas Alkis Pierides Kyproula Demetriou Olivier Devuyst Berenice Gitomer Marku Laakso Anne Lumiaho Klea Lamnissou Riccardo Magistroni Patrick Parfrey Martijn Breuning Dorien J.M. Peters Roser Torra Christopher G. Winearls Vicente E. Torres Peter C. Harris Andrew D. Paterson York Pei 《Journal of the American Society of Nephrology : JASN》2010,21(9):1510-1520
Significant variation in the course of autosomal dominant polycystic kidney disease ( ADPKD) within families suggests the presence of effect modifiers. Recent studies of the variation within families harboring PKD1 mutations indicate that genetic background may account for 32 to 42% of the variance in estimated GFR (eGFR) before ESRD and 43 to 78% of the variance in age at ESRD onset, but the genetic modifiers are unknown. Here, we conducted a high-throughput single-nucleotide polymorphism (SNP) genotyping association study of 173 biological candidate genes in 794 white patients from 227 families with PKD1. We analyzed two primary outcomes: (1) eGFR and (2) time to ESRD (renal survival). For both outcomes, we used multidimensional scaling to correct for population structure and generalized estimating equations to account for the relatedness among individuals within the same family. We found suggestive associations between each of 12 SNPs and at least one of the renal outcomes. We genotyped these SNPs in a second set of 472 white patients from 229 families with PKD1 and performed a joint analysis on both cohorts. Three SNPs continued to show suggestive/significant association with eGFR at the Dickkopf 3 (DKK3) gene locus; no SNPs significantly associated with renal survival. DKK3 antagonizes Wnt/β-catenin signaling, which may modulate renal cyst growth. Pending replication, our study suggests that genetic variation of DKK3 may modify severity of ADPKD resulting from PKD1 mutations.Autosomal dominant polycystic kidney disease ( ADPKD) is the most common monogenic kidney disease worldwide, affecting one in 500 to 1000 births.1,2 It is characterized by focal development of renal cysts in an age-dependent manner. Typically, only a few renal cysts are clinically detectable during the first three decades of life; however, by the fifth decade, tens of thousands of renal cysts of different sizes can be found in most patients.3 Progressive cyst expansion with age leads to massive enlargement and distortion of the normal architecture of both kidneys and, ultimately, ESRD in most patients. ADPKD is also associated with an increased risk for cardiac valvular defects, colonic diverticulosis, hernias, and intracranial arterial aneurysms. Overall, ADPKD accounts for approximately 5% of ESRD in North America.2Mutations of PKD1 and PKD2 respectively account for approximately 85% and approximately 15% of linkage-characterized European families. Polycystin-1 (PC-1) and PC-2, the proteins encoded by PKD1 and PKD2, respectively, function as a macromolecular complex and regulate multiple signaling pathways to maintain the normal tubular structure and function.1 Monoclonal expansion of individual epithelial cells that have undergone a somatic “second hit” mutation, resulting in biallelic inactivation of either PKD1 or PKD2, seems to provide a major mechanism for focal cyst initiation,4 possibly through the loss of polycystin-mediated mechanosensory function in the primary cilium.5 In addition, a large prospective, observational study indicated that renal cysts in ADPKD expand exponentially with increasing age, and patients with large polycystic kidneys are at higher risk for developing kidney failure6; however, the key factors that modulate renal disease progression in ADPKD remain incompletely understood.Renal disease severity in ADPKD is highly variable, with the age of onset of ESRD ranging from childhood to old age.7–11 A strong genetic locus effect has been noted in ADPKD. Adjusted for age and gender, patients with PKD1 have larger kidneys and earlier onset at ESRD than patients with PKD2 (mean age at ESRD 53.4 versus 72.7 years, respectively).8,9 By contrast, a weak allelic effect (based on the 5′ versus 3′ location of the germline mutations) on renal disease severity may be present for PKD110 but not PKD2.11 Marked intrafamilial variability in renal disease is well documented in ADPKD and suggests a strong modifier effect.10–15 In an extreme example, large polycystic kidneys were present in utero in one of a pair of dizygotic twins affected with the same germline PKD1 mutation, whereas the kidneys of the co-twin remained normal at 5 years of age.12 Several studies have quantified the role of genetic background in the phenotypic expression of ADPKD. In a comparison of monozygotic twins and siblings, greater variance in the age of onset of ESRD in the siblings supported a role for genetic modifiers.13 Two other studies of intrafamilial disease variability in PKD1 have estimated that genetic factors may account for 32 to 42% of the variance of creatinine clearance before ESRD and 43 to 78% of the variance in age at ESRD.14,15 The magnitude of the modifier gene effect from these studies suggests that mapping such factors is feasible. Here, we report the results of an association study of modifier genes for PKD1 renal disease severity. 相似文献
138.
Sandoval SB Stoyanova E Coll E Pastor S Reyes J Andrés E Ballarin J Xamena N Marcos R 《Mutagenesis》2010,25(6):603-608
Chronic renal failure (CRF) patients are considered to present genomic instability and, as a consequence, elevated levels of genetic damage. An open question is whether this damage is related to the stage of the pathology. To determine the background levels of genetic damage, a large population of 258 Caucasian adults (201 CRF patients and 57 controls) was analysed using the micronucleus (MN) assay. The frequency of MN in CRF patients was significantly higher than in controls and correlated with the progression of the disease, according to the glomerular filtration rate. In addition, a significant association was observed between genetic damage and serum creatinine levels. Genetic damage, measured as frequency of MN, increases when renal function decreases. The fact that an increased level of MN is already observed in patients' Stage 2 seems to indicate a genetic predisposition on these patients. Nevertheless, part of the observed damage can be attributed to the uraemic state itself. 相似文献
139.
140.